Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.

Lin H, de Stanchina E, Zhou XK, Hong F, Seidman A, Fornier M, Xiao WL, Kennelly EJ, Wesa K, Cassileth BR, Cunningham-Rundles S.

Cancer Immunol Immunother. 2010 Jun;59(6):885-97. doi: 10.1007/s00262-009-0815-3. Epub 2010 Feb 6.

2.

Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production.

Lin H, Cheung SW, Nesin M, Cassileth BR, Cunningham-Rundles S.

Clin Vaccine Immunol. 2007 Jan;14(1):21-7. Epub 2006 Nov 8.

3.

Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse.

Lin H, De Stanchina E, Zhou XK, She Y, Hoang D, Cheung SW, Cassileth B, Cunningham-Rundles S.

Exp Biol Med (Maywood). 2009 Mar;234(3):342-53. doi: 10.3181/0807-RM-226. Epub 2009 Jan 14.

6.
9.

Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.

Wesa KM, Cunningham-Rundles S, Klimek VM, Vertosick E, Coleton MI, Yeung KS, Lin H, Nimer S, Cassileth BR.

Cancer Immunol Immunother. 2015 Feb;64(2):237-47. doi: 10.1007/s00262-014-1628-6. Epub 2014 Oct 29.

11.

Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.

Lin H, She YH, Cassileth BR, Sirotnak F, Cunningham Rundles S.

Int Immunopharmacol. 2004 Jan;4(1):91-9.

PMID:
14975363
13.
14.

Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.

Ulich TR, del Castillo J, McNiece I, Watson L, Yin SM, Andresen J.

Am J Pathol. 1990 Aug;137(2):369-76.

15.

Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.

Patchen ML, Liang J, Vaudrain T, Martin T, Melican D, Zhong S, Stewart M, Quesenberry PJ.

Stem Cells. 1998;16(3):208-17.

17.

Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.

Benboubker L, Cartron G, Roingeard F, Delain M, Degenne M, Linassier C, Hérault O, Truglio D, Bout M, Petit A, Brémond JL, Desbois I, Colombat P, Binet C, Domenech J.

Exp Hematol. 2003 Jan;31(1):89-97.

PMID:
12543111
18.

Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.

Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M.

Blood. 1997 May 1;89(9):3186-91.

20.

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE Jr, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB, et al.

Blood. 1995 Jun 15;85(12):3452-6.

Supplemental Content

Support Center